EP3187213A1 — Syringe with click mechanism
Assigned to Galderma SA · Expires 2017-07-05 · 9y expired
What this patent protects
According to a first aspect of the invention a syringe comprisinga barrel, a plunger moveably arranged within said barrel and a plunger rod for driving said plunger is provided. The syringe comprises a first engagement member arranged at the plunger rod, said first engagement mem…
USPTO Abstract
According to a first aspect of the invention a syringe comprisinga barrel, a plunger moveably arranged within said barrel and a plunger rod for driving said plunger is provided. The syringe comprises a first engagement member arranged at the plunger rod, said first engagement member comprising a grooved surface and a second engagement member arranged at the barrel to engage with said grooved surface of the first engagement member such that feedback is given to a user as the plunger rod is moved relative to the barrel for driving said plunger. Wherein, for a given distance D travelled by the plunger rod relative the barrel, the first engagement member moves a distance d, wherein d≥D.
Drugs covered by this patent
- Ozempic (semaglutide) · Novo Nordisk
Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.
Track this patent
Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.